leisure time -WSS

leisure time

author：comprehensive 2025-10-01 21:40:28 - browse：97

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Vertex Pharmaceuticals may move headquarters in Boston

entertainment

WSS

Patient advocates debate FDA's accelerated approval process

Primary care physicians play key roles in Alzheimer's management

Advances in CAR

A new House health package & hospitals’ new site

Patient advocates debate FDA's accelerated approval process

Readout LOUD podcast: mifepristone case, GLP

focus

leisure time

knowledge

Supreme Court strikes down use of affirmative action

Food as medicine: Medically tailored meals may get standardized

What does generative AI mean for health care? We asked experts

Food as medicine: Medically tailored meals may get standardized

DIEP, the 'gold standard' of breast reconstruction, is under threat

How generative AI is inspiring dreams of a health data revolution

Guidelines to prevent youth baseball injuries need more muscle

How to protect patients from sexual assault

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Washington mulls new rules to avert another Change Healthcare

focus

Abortion pill case raises question: who can sue the FDA?

Ethical issues complicate the benefits of medical crowdfunding

How generative AI is inspiring dreams of a health data revolution

'Make People Better': The CRISPR babies story you probably don't know

Study says nonprofit hospitals fall short in charity care spending

How to protect patients from sexual assault

leisure time

focus

entertainment

hotspot